Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

UCSF Seminar: "Neuron-glia interactions regulate CNS node of Ranvier assembly."
Masitinib in Patients with Progressive or Relapse-Free Secondary Multiple Sclerosis
Boxed warning of HBV risk added to Rituxan, Arezerra
Oligodendrocyte development and myelination in GFP-transgenic zebrafish.
Alkali metals levels in the human brain tissue: Anatomical region differences and age-related changes.
A Safety and Efficacy Extension Study of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Flupirtine as Oral Treatment in Multiple Sclerosis (FLORIMS)
Central fatigue in multiple sclerosis: a review of the literature.
Social Support in Relation to Fatigue Symptoms Among Patients with Multiple Sclerosis.
Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis.
Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.
Gastro Effects Dog Oral MS Drug Tecfidera
Comparative effectiveness of early Natalizumab treatment in JC virus-negative relapsing-remitting multiple sclerosis.
A Complex Case of Neuro-Behçet's Disease in a Patient Previously Diagnosed with multiple Sclerosis: A Case Report.
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator.
Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis.
The cell biology of CNS myelination.
Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
Guillain-Barré Syndrome (42 Cases) Occurring During a Zika Virus Outbreak in French Polynesia.
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment.
Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.
Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling.
Teriflunomide in multiple sclerosis: Added benefit not proven
Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.
Hematopoietic stem cell transplantation for MS: extraordinary evidence still needed.

Pages